JAKAVI 15MG TABLET

icon
Novartis India Ltd

Composition for JAKAVI 15MG TABLET

iconPrescription Required

Primarily used for

Chronic Idiopathic Myelofibrosis
Potentiallyunsafewith
icon
Pregnancy
icon
Lactation
56547.62
₹4039.12/tablet
14 tablets in 1 strip
ADD TO CART

Substitutes for JAKAVI

No substitutes found for this medicine

Medicine Overview of JAKAVI TABLET

uses

Uses of JAKAVI TABLET

Jakavi 15mg tablet is used in the treatment of chronic idiopathic myelofibrosis.
uses

Side effects of JAKAVI TABLET

Common

Headache, Dizziness, Reduced blood platelets, Bruising, Anemia.

uses

How to use JAKAVI TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. It can be taken with or without food, but it is better to take Jakavi 15mg tablet at a fixed time.

How JAKAVI TABLET works

In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Jakavi 15mg tablet blocks this signal, and thus stops the production of these cancer cells.

In Depth Information on JAKAVI TABLET

Expert advice for JAKAVI TABLET

  • You will be recommended frequent blood tests (every 2 to 4 weeks) and your doctor can change the dosage based on your test reports.
  • Tell your doctor if you have or have had any infections such as tuberculosis (TB), hepatitis etc. or any disorders of the kidney, liver or any form of skin cancers.
  • Do not take ruxolitinib before a dialysis treatment.
  • Take necessary precautions as ruxolitinib may reduce the number of clot-forming cells (platelets) in your blood and the ability of your body to fight infection.
  • Seek immediate medical attention if you experience unexplained bruising, sudden bleeding, unusual tiredness, difficulty in breathing, pale skin, frequent infections, fever, chills, prolonged coughing, increased sweating at night, sudden weight loss, loss of balance, difficulties in walking/coordination, speaking difficulties, clumsiness, difficulty in thinking, blurring of vision, weakness on one side of body, painful skin rashes with blisters or any unusual skin changes.
  • Do not give ruxolitinib to children aged below 18 years.
  • Do not drive or operate machinery after using ruxolitinib as it may cause dizziness.
  • Tell your doctor if you are or planning to become pregnant or breastfeeding.
  • Do not take if allergic to ruxolitinib or any of its ingredients.
Warnings
Special precautions for JAKAVI 15MG TABLET
icon
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
icon
Pregnancy
WEIGH RISKS VS BENEFITS
Jakavi 15mg tablet may be unsafe to use during pregnancy.

Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
...
+more
icon
Lactation
CAUTION
Jakavi 15mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.
icon
Driving
CAUTION
icon
Kidney
CAUTION
Caution should be used in patients with renal impairment.
icon
Liver
There is no data available. Please consult doctor before consuming the drug.

Patient Concerns

Frequently asked questions for JAKAVI 15MG TABLET

Frequently asked questions for Ruxolitinib

Q. Is ruxolitinib available in India?
Yes, ruxolitinib is approved for marketing in India.

Top Medical Oncologists
doctor
Dr. Sandeep Batra
MBBS, MD, DNB, Diploma, DNB
5.0
doctor
Dr. Jawahar Ticku
MBBS, MD, Fellowship
4.3
doctor
5.0
doctor
Dr. Pratap K. Das
MBBS, MD, DM
4.4
doctor
Dr. Amish Vora
MBBS, MD, DNB, DNB
4.2